Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    On July 8, 2010, Alcon's independent director committee (IDC) had set up a $50 million litigation trust to ensure company's minority shareholders get the best deal from bidder Novartis AG. [15] On April 9, 2019, Alcon completed a 100% spin-off from Novartis. [4] [16] [17] The new standalone company is worth up to 28 billion Swiss francs. [18 ...

  3. Nepafenac - Wikipedia

    en.wikipedia.org/wiki/Nepafenac

    Nepafenac, sold under the brand name Nevanac among others, is a nonsteroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop 0.1% solution (Nevanac) or 0.3% solution (Ilevro). It is used to treat pain and inflammation associated with cataract surgery. [3] Nepafenac is a prodrug of amfenac, an inhibitor of COX-1 and COX-2 ...

  4. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis AG. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...

  5. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

  6. Novartis Aims to Beat $1.9B in Cost Savings By Year's End - AOL

    www.aol.com/2011/09/13/novartis-aims-to-beat-19b...

    Novartis (NYS: NVS) has two things to say. It now expects more bang for its buck from Alcon. The eye-care acquisition, which cost Novartis $51 billion, will deliver high single-digit to low double ...

  7. Novartis Obtains Final Shares of Alcon for $12.9 Billion - AOL

    www.aol.com/news/2010-12-15-novartis-obtains...

    Shares of Novartis (NVS) soared higher on Wednesday, after the Swiss drug maker finally obtained the remaining outstanding shares of Alcon (ACL) for $12.9 billion. Novartis had been trying to gain ...

  8. AOL Mail

    mail.aol.com

    Absolutely! It's quick and easy to sign up for a free AOL account. With your AOL account you get features like AOL Mail, news, and weather for free!

  9. Ciprofloxacin/dexamethasone - Wikipedia

    en.wikipedia.org/wiki/Ciprofloxacin/dexamethasone

    In clinical trials, the median time to cessation of ear pain in Ciprodex was five days in a sample population of 909 participants. However, the clinical trial failed to demonstrate any significant benefit of using the combination of active ingredients in Ciprodex over ciprofloxacin alone, in regards to ear pain.